Altre lingue Duality S.A.

Azioni

DUA

PLDLITY00010

Prezzo di chiusura Warsaw S.E. Altri mercati azionari 00:00:00 26/06/2024			Variaz. 5gg	Var. 1 gen.
1,515 ^PLN	-0,66%		-1,30%	+2,36%

15/05	Duality S.A. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
20/03	Duality S.A. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Duality S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Duality S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
BioNTech to Present Clinical Data Updates on Cancer Vaccine Candidates	11/03
Tod's CEO says he has no plans to sell 'family business'	23/02
LATE BRIEFING - Unternehmen und Märkte	31/01
BioNTech, Duality Biologics Obtain FDA Fast Track Designation for Ovarian Cancer Therapy Candidate	31/01
BioNTech's Cancer Therapy Candidate Obtains Fast-track Designation from US FDA	31/01
BioNTech, Duality Biologics Initiate Phase 3 Trial of Breast Cancer Drug	22/01
BioNTech Begins Late-stage Study for Metastatic Breast Cancer Therapy Candidate	22/01
Biontech treibt mit Partner Entwicklung von Krebsmittel voran	22/01
BioNTech challenges AstraZeneca with breast cancer precision drug trial	22/01
LATE BRIEFING - Unternehmen und Märkte -2-	21/12
BioNTech, Duality Biologics Get US FDA Breakthrough Therapy Designation for Uterine Cancer Drug Candidate	21/12
Duality S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Australia's Albanese to highlight trade on China visit as ties warm	03/11
Duality S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Introducing Janus, the exotic 'two-faced' white dwarf star	21/07/23
HBM Holdings, Beigene Sign License Deal for Antibody-Drug Conjugate Program; HBM Shares Soar 20%	14/07/23
Duality S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
LATE BRIEFING - Unternehmen und Märkte	03/04/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Duality S.A.

Azioni

DUA

PLDLITY00010

Altre lingue

Filtri